Pharmacodynamic aspects of sustained release preparations

Area of Science:

• Pharmacology
• Drug Delivery Systems
• Pharmacokinetics/Pharmacodynamics

Background:

• Sustained release (SR) drug administration offers distinct advantages over intermittent dosing.
• Key features include minimized peak-and-trough drug concentrations and reduced physiological counteraction.
• The non-linear relationship between drug concentration and effect (pharmacodynamics) is crucial.

Purpose of the Study:

• To analyze the impact of sustained release (SR) drug administration on pharmacologic and clinical outcomes.
• To elucidate how SR properties interact with pharmacodynamic profiles.
• To highlight the importance of pharmacodynamic considerations in drug development and clinical application.

Main Methods:

• Conceptual analysis of sustained release (SR) pharmacokinetics and pharmacodynamics.
• Comparison of SR versus intermittent (pulsatile) drug administration effects.
• Evaluation of drug exposure time versus AUC as a relevant parameter for SR drugs.

Main Results:

• SR administration minimizes drug concentration fluctuations and physiological counteraction.
• The impact of SR varies based on the pharmacodynamic profile and concentration range.
• Exposure time, not AUC, is often key for SR drugs with non-concentration-dependent pharmacodynamics.
• SR can minimize hysteresis and influence therapeutic/adverse effects based on administration site.

Conclusions:

• Mode of drug administration profoundly influences pharmacological and clinical outcomes.
• Sustained release (SR) offers unique benefits by optimizing drug exposure and minimizing physiological responses.
• Pharmacodynamic principles must be integrated throughout drug development and clinical use for optimal efficacy and safety.